About Abide Therapeutics
Abide Therapeutics is a company based in San Diego (United States) founded in 2011 was acquired by Lundbeck in May 2019.. Abide Therapeutics has raised $12.2 million across 2 funding rounds from investors including Lundbeck and Cardinal Partners. The company has 47 employees as of December 31, 2017. Abide Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter San Diego, United States
- Employees 47 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Abide Therapeutics
Abide Therapeutics has successfully raised a total of $12.2M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $10.0M
-
First Round
First Round
(17 Nov 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2014 | Amount | Series B - Abide Therapeutics | Valuation |
investors |
|
| Nov, 2011 | Amount | Seed - Abide Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abide Therapeutics
Abide Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Lundbeck and Cardinal Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in early stage companies in the US
|
Founded Year | Domain | Location | |
|
Drugs for CNS disorders are developed and advanced.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abide Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Abide Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abide Therapeutics Comparisons
Competitors of Abide Therapeutics
Abide Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abide Therapeutics
Frequently Asked Questions about Abide Therapeutics
When was Abide Therapeutics founded?
Abide Therapeutics was founded in 2011.
Where is Abide Therapeutics located?
Abide Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Abide Therapeutics a funded company?
Abide Therapeutics is a funded company, having raised a total of $12.2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.2M, raised on Nov 17, 2011.
How many employees does Abide Therapeutics have?
As of Dec 31, 2017, the latest employee count at Abide Therapeutics is 47.
What does Abide Therapeutics do?
Abide Therapeutics investigates serine hydrolase inhibitors for pain management. It uses a proprietary drug development platform to generate lead molecules for inhibition of serine hydrolase activity. Its lead candidate targets monoacylglycerol lipase, a type of serine hydrolase, in the endocannabinoid system. It mimics the analgesic effects of marijuana without affecting cognition and is currently in phase I clinical trials.
Who are the top competitors of Abide Therapeutics?
Abide Therapeutics's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
Who are Abide Therapeutics's investors?
Abide Therapeutics has 2 investors. Key investors include Lundbeck, and Cardinal Partners.